Angelica Tiotiu1, Nathalie Wirth1 and Yves Martinet1
Pulmonology, CHRU, Nancy, France
In asthmatics patients, tabacco smoking is associated with accelerated
decline in pulmonary function, poor disease control and reduced
responsiveness to corticosteroids.
Our objective was to compare asthma control efficiency in a population
of asthmatic patients according to smoking status.
We compared 3 equal groups of 30 asthmatics patients: group 1 never
smokers, group 2 former smokers and group 3 current smokers. We
collected demographic, clinical data, hospital anxiety/depression (HAD)
score, functional respiratory data and asthma control scores (ACQ6) for
The three groups were identical in terms of demographical data (mean
age 42 vs 46 vs 44.5 years) and lung function: FEV1=80.6%, FVC=94.07%,
FEV1/FVC=0.72 in group 1, FEV1=80.9%, FVC=99.16%, FEV1/FVC=0.68 in
group 2 and FEV1=79.21%, FVC=96.04%, FEV1/FVC=0.69 in group 3
(p=0.457). Anxiety defined by an HAD ≥8 was present in 46.67%
patients in group 1, 53.33% in group 2 and 23.33% in group 3. Mean ACQ6
score was significantly higher in group 3 vs group 2 (1.73 vs 1.23,
p=0.003), and vs group 1 (1.17; p=0.003), without significant
difference between group 1 and 2 (p=0.416). According to ACQ6, 9
patients in group 1 had an uncontrolled asthma, 11 in group 2 and 15 in
group 3. Dyspnea sensation was significantly lower in group 3 vs group
In conclusion, current smokers had underestimated dyspnea, lower
anxiety, and poorer asthma control than nonsmokers or former smokers.
These observations stress the importance of smoking cessation to help
achieve asthma control.
Image : http://www.uc.edu/profiles/...